Showing Form 4 filings for JNJ
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Johnson & Johnson
Price
$212.42
Shares
43,940
Ownership
947,261
Value/Share
Joseph Wolk
CFO
Healthcare
Industry
$196.95
33,990
958,627
Joaquin Duato
CEO
$204.64
26,872
110,915
$207.16
30,924
401,381
VP Operations
VP
$214.65
13,619
1,007,970
$203.27
23,479
354,049
Chief Operating Officer
COO
$202.83
29,631
644,441
$206.06
45,041
195,493
$205.75
4,322
540,762
$207.52
4,314
662,765
$211.38
10,627
284,427
Board Director
Dir
$206.23
31,290
871,866
$197.18
8,081
640,073
$198.54
32,225
87,689
$207.92
3,385
954,196
$200.07
25,818
184,885
$202.38
20,884
217,309
$206.71
46,787
70,030